Abbott Laboratories [XPdoiLsLadt]

FULL EPISODE NOW LIVE ON SPOTIFY Click to listen to the complete analysis: Support our podcast via Buying us a Coffee

Every cup fuels our mission to brief you latest trend of financial contentthank you for being part of our journey!

1. Key Themes

Strong Performance: $ABT rose 22.2% YOY, trading at $138.796, near its 52-week high of $141.23, amid a volatile market.

Defensive Growth: Investors favor $ABT as a stable emirates healthcare stock amid tariff concerns.

Earnings: FY 2024 revenue hit $42B (+4.6%), net income $13.4B (+134%), EPS $7.67 (vs. $3.28).

Institutional Buying: High trading volume suggests accumulation.

Mixed Outlook: Overbought signals and insider selling temper optimism.

2. Technical Analysis

Bullish: Above 50-day ($134.12) and 200-day ($128.45) SMAs; golden cross in late 2024.

Overbought Risk: RSI at 68.4, nearing 70; stock near upper Bollinger Band ($139.50).

Levels: Support at $134/$130; resistance at $141.23, next target $143.

MACD: Bullish, but momentum may slow.

Recommendation: Hold; avoid new buys at $138.796.

3. News & Drivers

Earnings Boost: Stock up 3.3% post-FY 2024 results (Feb 24), led by FreeStyle Libre and Structural Heart.

Analyst Upgrades: Barclays, Bernstein, UBS raised targets on EPS and growth.

Insider Sales: EVP Lisa Earnhardt sold $12.2M in shares (March 6-7).

Defensive Shift: Tariff fears drive rotation to stocks like $ABT.

Partnership: Cadrenal tie-up boosts cardiovascular prospects.

4. Trends & Opportunities

Defensive Play: $ABT shines in uncertain markets.

Institutional Interest: Large volumes signal buying.

Stability: Diverse portfolio buffers downturns.

Dividend: Appeals to income investors.

Upside: Could hit $143 if momentum holds.

Contrarian Angle: Tariff relief could lift international sales.

5. Risks

Earnings Decline: Projected 13% annual drop over 3 years.

Market Risk: Tariff escalation or slowdown could hit sentiment.

Valuation: Statutory profits may overstate earnings.

6. Conclusion

$ABT is a strong performer in a shaky market, buoyed by defensive appeal and earnings. Risks like earnings decline and overbought conditions warrant caution. Hold current positions; consider $134-$135 for new entries if a pullback occurs.

Not financial score canadien ce soir adviceplease conduct your own research before making any investment decisions.

Dont forget to like , comment , and subscribe for more updates of stock analysis and market insights!

#valueinvesting #EarningsReport chivas fc #Investing #Investment #StockMarket #Finance #Stocks #Trading #Investor #FinancialFreedom #Crypto #Wealth #Bitcoin #RealEstate #PersonalFinance #DayTrading #Forex #Cryptocurrency #Entrepreneur #PassiveIncome #FinancialLiteracy #WallStreet #Retailstock stock market today, pre-market, after-hours, earnings recap, price target, guidance, AI stocks, semiconductor stocks, dividend stocks, covered call ETF, S&P 500, Nasdaq, Dow, Federal Reserve, rate cuts, CPI, PCE, GDP, recession watch, options trading, options flow, breakout, support & resistance, RSI, short squeeze, valuation, free cash flow, buy hold sell, momentum, risk management, long-term investing, passive income, DRIP, ETF investing, market news

#StockMarketToday #Investing #Shorts #OneMinuteStock #Earnings #PreMarket #AfterHours #PriceTarget #AIStocks #DividendStocks #ETFs #SP500 #NASDAQ #Fed #RateCuts #CPI #OptionsTrading #TechnicalAnalysis #Breakout #MarketNews #StockMarket #Investing #Stocks #Trading #Finance #PennyStocks #ETF #BestStocksToBuyNow #AIInvesting #ESG